TenderDekho Logo
GEM

Tender Notice for Diethylcarbamazine 50mg tab,Enalapril 2.5mg tab,ED Fluconazole 0.3percent,ED Flurbiprofen Sodium 0. in CENTRAL DELHI, DELHI

Bid Publish Date

13-Jan-2025, 3:44 pm

Bid End Date

25-Feb-2025, 4:00 pm

Progress

RA
Issue13-Jan-2025, 3:44 pm
Reverse Auction12-Apr-2025, 12:00 pm
AwardPending
Explore all 5 tabs to view complete tender details

Quantity

22380

Category

Diethylcarbamazine 50mg tab

Bid Type

Two Packet Bid

Categories 6

Public procurement opportunity for Indian Army Diethylcarbamazine 50mg tab, Enalapril 2. 5mg tab, ED Fluconazole 0. 3percent, ED Flurbiprofen Sodium 0. 3 percent 5ml, Fusidic acid Oint cream, Levenorgestrol 0. 25 plu sEthnylestradoil 0. 05mg pack of 21 tab, Lamotrigine 50mg tab, Methotrexate 10mg tab, Megesterol Acetate 40mg tab in CENTRAL DELHI, DELHI. Quantity: 22380 issued by. Submission Deadline: 25-02-2025 16: 00: 00. View full details and respond.

Additional Tender Data

Commercial Details

Tender Category

Goods

Bid To RA

No

Bid To RA Enabled

No

Item Category

Diethylcarbamazine 50mg tab , Enalapril 2.5mg tab , ED Fluconazole 0.3percent , ED Flurbiprofen Sodium 0.3 percent 5ml , Fusidic acid Oint cream , Levenorgestrol 0.25 plu sEthnylestradoil 0.05mg pack of 21 tab , Lamotrigine 50mg tab , Methotrexate 10mg tab , Megesterol Acetate 40mg tab

Authority Records

MINISTRY OF DEFENCEMILITARY AFFAIRS DEPARTMENTINDIAN ARMY

BID & GeM Expert Consultancy

End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.

Bid Preparation GeM Registration Document Filing

Free consultation · 24h response

Documents 5

GeM-Bidding-7371494.pdf

Main Document

BOQ Document

BOQ

BOQ Document

BOQ

Buyer uploaded ATC document

ATC

GEM General Terms and Conditions Document

GEM_GENERAL_TERMS_AND_CONDITIONS

Bill of Quantities (BOQ) 9 Items Sign in for GEM prices

#1

Diethylcarbamazine 50mg tab

Diethylcarbamazine 50mg tab

300 no Delivery: 15 days
#2

Enalapril 2.5mg tab

Enalapril 2.5mg tab

7,800 no Delivery: 15 days
#3

ED Fluconazole 0.3percent

ED Fluconazole 0.3%

30 bott Delivery: 15 days
#4

ED Flurbiprofen Sodium 0.3 percent 5ml

ED Flurbiprofen Sodium 0.3% 5ml

480 no Delivery: 15 days
#5

Fusidic acid Oint cream

Fusidic acid Oint cream

540 no Delivery: 15 days
#6

Levenorgestrol 0.25 plu sEthnylestradoil 0.05mg pack of 21 tab

Levenorgestrol 0.25+Ethnylestradoil 0.05mg pack of 21 tab

30 pkt Delivery: 15 days
#7

Lamotrigine 50mg tab

Lamotrigine 50mg tab

5,840 no Delivery: 15 days
#8

Methotrexate 10mg tab

Methotrexate 10mg tab

3,060 no Delivery: 15 days
#9

Megesterol Acetate 40mg tab

Megesterol Acetate 40mg tab

4,300 no Delivery: 15 days

Required Documents

1

Experience Criteria

2

Past Performance

3

Bidder Turnover

4

Certificate (Requested in ATC)

5

OEM Authorization Certificate

6

OEM Annual Turnover

7

Additional Doc 1 (Requested in ATC)

8

Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria

9

the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Reverse Auction Schedule

Completed

Start

12-Apr-2025, 12:00 pm

End

14-Apr-2025, 12:00 pm

Duration: 48 hours

Reverse Auction Document

✅ RA concluded. Check financial results for final rankings.

Technical Results

S.No Seller Item Date Status
1
**********   Under PMA
-25-02-2025 10:37:38
2
**********   Under PMA
-22-02-2025 16:54:43
3
**********   Under PMA
-04-02-2025 18:30:55
4
**********   Under PMA
-25-02-2025 15:59:52
5
**********   Under PMA
-23-02-2025 09:40:11
6
**********   Under PMA
-25-02-2025 13:18:53
7
**********   Under PMA
-22-02-2025 11:59:41
8
**********   Under PMA
-21-02-2025 12:28:30
9
**********   Under PMA
-22-02-2025 15:33:19
10
**********   Under PMA
-25-02-2025 14:22:02
11
**********   Under PMA
-22-02-2025 17:26:09
12
**********   Under PMA
-22-02-2025 16:03:14
13
**********   Under PMA
-22-02-2025 19:34:42
14
**********   Under PMA
-25-02-2025 15:26:58
15
**********   Under PMA
-19-02-2025 22:32:02
16
**********   Under PMA
-25-02-2025 13:22:54
17
**********   Under PMA
-22-02-2025 13:46:22
18
**********   Under PMA
-24-02-2025 15:55:51

Frequently Asked Questions

Key insights about DELHI tender market

What are the eligibility requirements for participating in the tender?

The eligibility requirements include being a registered entity and having the capability to fulfill the procurement needs specified in the tender. Bidders must provide evidence of compliance with experience and previous performance standards, as well as financial turnover documentation. Additionally, specific certifications must accompany the tender submissions.

What are the required certificates for submission?

Bidders must submit a range of required certificates including OEM authorizations, proof of past performance, and financial turnover, as outlined in the tender documents. It is crucial that all certifications adhere to established industry standards to ensure compliance.

What is the registration process for bidders?

The registration process involves submitting all necessary documents and certifications as indicated in the tender submission guidelines. Bidders must ensure that their entity is registered under the relevant trade laws and provides the required documentation to prove eligibility.

Which document formats are accepted for submission?

Accepted document formats include PDF and other specified formats detailed in the tender documentation. Bidders are encouraged to ensure that all documents such as compliance certifications and financial documents are presented in the formats listed to avoid non-compliance.

What are the technical specifications for the medicines required in this tender?

The technical specifications for the medicines are outlined specifically in the tender document. Bidders must ensure that all products meet the required dosage and formulation standards to qualify for evaluation.

What quality standards must the products adhere to?

Products must comply with established quality standards including compliance with applicable pharmaceutical regulations and certifications. Bidders should demonstrate compliance with all necessary quality assurance measures during the evaluation process.

What are the compliance requirements for bidders?

Bidders must demonstrate compliance with all compliance requirements outlined in the tender. This includes adhering to regulations related to product quality, documentation, and financial transparency.

What are the performance security requirements for this tender?

Performance security requirements generally include a specified percentage of the contract value to ensure that successful bidders fulfill their contractual obligations. Detailed requirements are provided in the tender documentation.

What are the payment terms associated with this tender?

Payment terms, including schedules and methods, are detailed in the tender documents. Bidders are advised to review these terms carefully to understand their obligations and rights regarding payment.

How will the price evaluation be conducted?

Price evaluation considerations will be based on the overall competitiveness of the tender submissions, including pricing, compliance with technical specifications, and the supplier's capability to meet delivery timelines.

What methods are available for submitting documents?

Bidders can submit documents electronically through the specified submission portal indicated within the tender instructions. All submissions must comply with the guidelines laid out in the tender documentation.

Are there any key timelines bidders should be aware of?

Bidders should be aware of all key timelines and deadlines stated in the tender documents. Timely submissions are critical to the consideration process, and adherence to these schedules is essential.

What is the evaluation and selection process for bids?

The evaluation and selection process will involve rigorous examination of bids against the outlined criteria. Bids will be assessed on technical compliance, cost-effectiveness, and overall capability.

How and when will results be notified to bidders?

Notification of results will typically occur following the completion of the evaluation process, with communications directed to all participating bidders according to the timelines outlined in the tender.

What benefits do Micro, Small, and Medium Enterprises (MSEs) receive in this tender?

The tender includes specific provisions that favor Micro, Small, and Medium Enterprises (MSEs), including exemptions from certain criteria related to experience and financial turnover. This encourages wider participation from smaller entities.

What provisions exist for startups in this tender?

Startups may benefit from special provisions related to compliance requirements, including relief from stringent documentation needs that typically apply to more established entities. They are encouraged to provide supporting documentation validating their eligibility for these exemptions.

How does this tender align with 'Make in India' policies?

The tender aligns with 'Make in India' policies by promoting local production and sourcing of pharmaceutical products. Bidders are encouraged to meet local content requirements and contribute to fostering domestic manufacturing capabilities in pharmaceuticals.